170737 ⎘
Post-translational modifications [PTMs] in chemical analysis of biological material phosphorylation
METHODS AND KITS FOR MEASURING THREE OR MORE TAU EPITOPES
#2BIOMARKERS FOR DETECTING AND/OR DETERMINING A TREATMENT REGIMEN FOR ALZHEIMER'S DISEASE
#3METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE
#4Anti-TDP-43 Binding Molecules
#5Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress
#6METHODS OF DETECTING DDR1 PHOSPHORYLATION
#7APPARATUS FOR MEASURING KINASE ACTIVITY WITH A FUNCTION OF DETERMINING THE NUMBER OF EFFECTIVE PHOSPHORYLATION SITES AND METHOD THEREOF
#8METHOD FOR SIMULATING SENSITIVE RESPONSE OF JURKAT CELLS IN MECHANICAL MICROENVIRONMENTS
#9Phosphorylated Neurofilament Heavy Chain Protein as a Biomarker of Blast-Induced Traumatic Brain Injury
#10FLUORESCENTLY-LABELED F-ACTIN PROTEIN BIOSENSORS AND METHODS OF HIGH-THROUGHPUT DRUG DISCOVERY
#11USE OF ABCG1 PHOSPHORYLATION SITE AS TUMOR BIOMARKER
#12THERAPEUTIC ROLE OF mTORC1 INHIBITION OF NON-TUMOR CELLS
#13METHODS FOR DETECTION OF ANALYTES
#14PHOSPHO-TAU AGGREGATION-BASED BIOMARKERS FOR ALZHEIMER'S DISEASE DIAGNOSIS, DIFFERENTIATION, AND TREATMENT
#15METHODS AND COMPOSITIONS FOR TAUOPATHY DIAGNOSIS AND TREATMENT
#16DIAGNOSTIC METHOD
#17QUANTIFICATION OF LIGAND BIAS AND MUTATION-INDUCED SIGNALING BIAS IN EGFR PHOSPHORYLATION IN DIRECT RESPONSE TO LIGAND BINDING
#18PHOSPHORYLATION OF P53 AS A PROGNOSTIC OR DIAGNOSTIC MARKER FOR THE TREATMENT OF SENESCENT CELLS IN A MAMMAL
#19METHODS FOR DETECTING CSF TAU SPECIES WITH STAGE AND PROGRESSION OF ALZHEIMER'S DISEASE, AND USE THEREOF
#20METHODS FOR DETECTION OF POST-TRANSLATIONAL MODIFICATIONS
#21METHODS FOR ASSESSING LIKELIHOOD OF POST-OPERATIVE DELIRIUM IN PATIENTS UNDERGOING SURGERY
#22PHOSPHORYLATED AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#23COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME
#24COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES WITH ISOCITRATE DEHYDROGENASE 1/2 MUTATIONS
#25ANTIBODIES TARGETING PHOSPHORYLATED SEVEN-TRANSMEMBRANE RECEPTORS
#26MOLECULAR IDENTIFICATION OF COMPOUNDS TARGETING TRISTETRAPROLIN (TTP) AND TTP PHOSPHORYLATION
#27PHOSPHORYLATED TRISTETRAPROLIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR ANTIAGING DRUGS
#28COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING KIDNEY INJURY
#29METHOD FOR EVALUATING RESIDUAL PLATELET THROMBOTIC POTENTIAL IN PATIENTS UNDERGOING ANTIPLATELET TREATMENT
#30COMPONENT ASSAY FOR ALZHEIMER'S DISEASE IN A LIVING SUBJECT
#31ANTIBODY FOR IDENTIFYING PHOSPHORYLATION-SPECIFIC REACTIONS OF THREONINE AT POSITION 1010 OF NCAPG2, AND USE THEREOF
#32SYSTEMS AND METHODS FOR IDENTIFYING AND TREATING NEURODEGENERATIVE DISEASE
#33SINGLE DOMAIN ANTIBODY SPECIFIC FOR PHOSPHORYLATED H2AX AND ITS USES
#34USE OF PHOSPHO-KERATIN 8 AS A BIOMARKER FOR DETECTING DIVIDING CANCER CELL
#35MATERIALS AND METHODS FOR DIFFERENTIATING CREB REGULATEDTRANSCRIPTION COACTIVATOR 3
#36TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS
#37DIAGNOSIS OF AUTISM SPECTRUM DISORDER BY MULTIOMICS PLATFORM
#38METHOD FOR ESTIMATING THE TOXICITY LEVEL OF RADIATION THERAPY ON A PATIENT
#39Inhibitors of the tissue factor-protease activated receptor 2 (TF-PAR2) signaling pathway for use in the treatment or prevention of heart failure (HF) and associated or resulting diseases
#40HETEROCYCLIC INHIBITORS OF EGFR AND/OR HER2, FOR USE IN THE TREATMENT OF CANCER
#41METHODS AND COMPOSITIONS FOR DETECTING COGNITIVE DISORDER
#42METHOD FOR QUANTIFYING CPG-CONTAINING OLIGONUCLEOTIDES IN COMPOSITIONS COMPRISING ALUM
#43Method for Determining Sensitivity to an Antineoplastic Agent
#44METHODS AND KITS FOR CLASSIFYING SOLID CANCER-AFFLICTED PATIENTS BASED ON RELB LABELLING
#45METHODS OF TREATING DISEASES AND DISORDERS
#46Compositions and methods involving engineered P27
#47METHODS OF TREATING MALIGNANT GLIOBLASTOMA
#48BIOMARKERS FOR CBL, AND COMPOSITIONS AND METHODS FOR THEIR USE
#49METHODS AND COMPOSITIONS RELATING TO BIOMARKERS FOR NEURODEGENERATIVE DISEASES
#50Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies
#51SECRETED PHOSPHORYLATED HEAT SHOCK PROTEIN-70 AS A BIOMARKER FOR TREATING AND DIAGNOSING CANCER
#52MARKER OF CALCIUM-OVERLOAD-MEDIATED NEURONAL DEATH AND APPLICATION THEREOF
#53COMPOSITIONS AND METHODS OF PREDICTING TIME TO ONSET OF LABOR
#54BIOMARKER FOR CANCER IMMUNOTHERAPY AND USE THEREOF
#55CSF PHOSPHORYLATED TAU AND AMYLOID BETA PROFILES AS BIOMARKERS OF TAUOPATHIES
#56Methods and compositions for determining the functional activity of DNA double strand break repair pathway molecules for assessing germline risk of cancer
#57DISEASE PATHWAY-BASED METHOD TO GENERATE BIOMARKER PANELS TAILORED TO SPECIFIC THERAPEUTICS FOR INDIVIDUALIZED TREATMENTS
#58Detection and quantification of AKT-mTOR pathway proteins
#59COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS
#60MICROVESICLE HISTONE H2AX AS A BIOMARKER FOR GENOTOXIC STRESS
#61ISOBARIC STABLE ISOTOPE-CONTAINING PHOSPHORYLATED PROTEIN LABELING REAGENT, AND PREPARATION METHOD AND APPLICATION THEREOF
#62Uses of Tau Phosphosites as Biomarkers for Alzheimer's Disease
#63CHARACTERIZATION AND LOCALIZATION OF PROTEIN MODIFICATIONS
#64Method for Diagnosing Cancer, Cancer Diagnosis Composition, Cancer Diagnosis Kit, Method for Evaluating State of Cancer, and Method for Screening Agents for Preventing and/or Treating Cancer
#65Liquid Chromatography Assay for Determining AAV Capsid Ratio
#66PHOSPHORYLATED AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#67BLOOD-BASED ASSAY FOR DIAGNOSING AND TREATING BASED ON SITE-SPECIFIC TAU PHOSPHORYLATION
#68Methods for Viral Particle Characterization Using Two-Dimensional Liquid Chromatography-Mass Spectrometry
#69PROTEOGENOMIC METHODS FOR DIAGNOSING CANCER
#70SYSTEMS AND METHODS FOR SINGLE-STRAND BREAK SIGNALING AND REPAIR IN A CELL-FREE SYSTEM AND METHODS OF IDENTIFYING MODULATORS OF SINGLE-STRAND BREAK SIGNALING AND REPAIR
#71BIOMARKERS FOR NEURODEGENERATIVE DISORDERS
#72METHOD AND KIT FOR DETERMINING BENEFIT OF CHEMOTHERAPY
#73Method for Predicting Therapeutic Response to Serine-Theronine Kinase Braf Inhibitor Drugs
#74DIAGNOSTIC METHOD BASED ON LARGE SCALE IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS
#75MARKER FOR DIAGNOSING COLORECTAL CANCER AND METHOD FOR PROVIDING INFORMATION REQUIRED FOR DIAGNOSIS OF COLORECTAL CANCER
#76Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress
#77NOVEL BIOMARKER FOR ALZHEIMER'S DISEASE IN HUMAN
#78Methods of Detecting and Treating a Tumor Expressing PT346 PDK1
#79Blood state analysis apparatus, blood state analysis system, blood state analysis method, and program
#80Assays for detecting modified compounds
#81Composition comprising material for regulating OCT4 modification to repress stemness
#82ANTIBODY CONJUGATE
#83Compositions and methods for diagnosing and/or treating kidney injury
#84Methods and materials for identifying and treating cancers having elevated levels of phosphorylated ubiquitin
#85Compositions and methods for predicting therapeutic outcome
#86METHODS FOR PRECISION THERAPEUTIC TARGETING OF HUMAN CANCER CELL MOTILITY AND KITS THEREOF
#87PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK1 INHIBITORS
#88SINGLE MOLECULE SEQUENCING IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATIONS ON PROTEINS
#89METHOD FOR DIAGNOSING LIVER DISEASES AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR LIVER DISEASES USING CHANGES IN EXPRESSION OF TM4SF5 PROTEIN
#90Phospho-Rab antibodies, assays and methods of use thereof
#91METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL
#92Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
#93DETECTION OF PHOSPHO-SERINE 129 ALPHA-SYNUCLEIN IN BLOOD CELLS AS A BIOMARKER FOR SYNUCLEINOPATHIES
#94Cofilin phosphorylation for quantifying CD4 T cell damage and predict CD4 T cell recovery from anti-retroviral therapy
#95Methods for simultaneous detection of analytes and apparatuses for practicing same
#96METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#97Methods of detecting and treating pulmonary hypertension
#98Marker for identifying patients with gliobastoma who respond positively to the drug regorafenib
#99Compositions and methods involving engineered p27
#100DETECTION OF ALZHEIMER'S DISEASE (AD), FRONTOTEMPORAL LOBAR DEGENERATION (FTLD), AMYOTROPHIC LATERAL SCHLEROSIS (ALS), PARKINSON'S DISEASE (PD), AND DEMENTIA WITH LEWY BODIES (DLB) INDICATED BY PHOSPHORYLATION OF MARCKS
#101ASSAYS TO DETECT NEURODEGENERATION
#102Sulfonylamide compounds as CDK2 inhibitors
#103Stratification of acute myeloid leukaemia patients for sensitivity to kinase pathway inhibitor therapy
#104Anti-tumor immunotherapy enhancer
#105Methods and compositions for assessing germline risk of cancer
#106TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#107Method for predicting the response of non-small-cell lung carcinoma patients to a medicament
#108Methods for detecting Na/K-ATPase-mediated Src signaling for diagnosis and prognosis of cancer
#109Assays to detect neurodegeneration
#110Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#111Methods for predicting and determining responsiveness to activators of JNK kinase
#112Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof
#113System for monitoring post-translational modification of protein using bio-sensor with gap and manufacturing method for bio-sensor
#114Kit for monitoring, detecting and staging GVHD
#115METHODS APPARATUSES AND SYSTEMS FOR DETECTING AND QUANTIFYING PHOSPHOPROTEINS
#116Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )
#117Methods for protein tyrosine phosphorylation profiling with variant SH2 domains
#118PHOSPHORYLATION OF HISTONES AND USES THEREOF
#119Specific Increase of Dopamine Synthesis THrough Targeting of the Guanylate Cyclase 2C Receptor in the Treatment of Parkinson's Disease
#120DISTINGUISHING ANTAGONISTIC AND AGONISTIC ANTI B7-H1 ANTIBODIES
#121Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
#122DISEASE PATHWAY-BASED METHOD TO GENERATE BIOMARKER PANELS TAILORED TO SPECIFIC THERAPEUTICS FOR INDIVIDUALIZED TREATMENTS
#123Assays to detect neurodegeneration
#124SH2 DOMAIN VARIANTS
#125Compositions and methods for diagnosing and/or treating kidney injury
#126ASSAY FOR DETECTING TOTAL AND S129 PHOSPHORYLATED ALPHA-SYNUCLEIN
#127METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#128Acylated insulin analogues and uses thereof
#129Methods of detecting and treating a tumor expressing pT346 PDK1
#130Assays for detecting modified compounds
#131DETECTION AND TREATMENT OF CANCER
#132Tau protein-binding DNA aptamers with capture/detection and therapeutic utilities in tauopathy-related neurodegenerative disorders
#133Screening method of anticancer agent focused on function of HP1 and evaluation system
#134Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#135METHODS TO DETECT NON-GENOTOXIC CARCINOGENS USING FLATWORMS
#136Method for measuring phosphorylated tau protein
#137Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
#138Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic recurrence
#139Use of phospho-Akt as a biomarker of drug response
#140METHODS OF CHARACTERISING CANCER
#141ERBB4 activator screening assay
#142ANTIBODIES RECOGNIZING PHOSPHORYLATION AT SPECIFIC AMINO ACID RESIDUES OF TRANSACTIVE RESPONSE DNA-BINDING PROTEIN 43
#143Methods of detecting progesterone receptor and of detecting an expression level
#144KITS FOR STRATIFYING SCOLIOTIC SUBJECTS
#145Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications
#146Modulators of protein tyrosine phosphatase and uses thereof
#147ANTIBODIES SPECIFIC TO PHOSPHORYLATED OCT4 AND USE THEREOF
#148A Method Of Assessing Protein Modification Status And Identifying Biomarkers Linked To Cell Signaling Pathways
#149Method for analyzing posttranslational modifications using GEL IEF and mass spectrometry
#150Method for monitoring cancer and/or inflammatory reaction based on RelB phosphorylation
#151Protein standard compositions and methods of making and using the same
#152Composition for inhibiting growth or proliferation of chronic myelogenous leukemia cancer stem cells, and screening method therefor
#153BIOMARKERS ASSOCIATED WITH CDK INHIBITORS
#154Methods to detect non-genotoxic carcinogens using flatworms
#155BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#156METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#157TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#158Synergistic cancer treatment
#159METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#160THE PROTEIN KINASE ACTIVITY OF PHOSPHOGLYCERATE KINASE 1 AS A TARGET FOR CANCER TREATMENT AND DIAGNOSIS
#161Methods of diagnosing and treating autism spectrum disorders
#162Methods and compositions for reducing blood glucose levels
#163METHODS FOR TISSUE SAMPLE FIXATION USING AN EXTENDED SOAK IN ALDEHYDE-BASED SOLUTIONS
#164Methods and compositions for assessing germline risk of cancer
#165PHOSPHORYLATION OF HISTONES AND USES THEREOF
#166Method of predicting obesity comprising measuring neurotensin
#167Modulation of PTPRA to treat arthritis
#168COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CONDITIONS INVOLVING HSF1 ACTIVITY
#169METHODS FOR ASSESSING BIOLOGICAL SAMPLE QUALITY
#170Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
#171Lung cancer adjuvant therapy
#172USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
#173Tyrosine kinase biosensors and methods of use
#174METHODS AND PRODUCTS RELATING TO GSK3ß REGULATION
#175METHODS FOR TREATMENT AND PREVENTION OF TAUOPATHIES AND AMYLOID BETA AMYLOIDOSIS BY MODULATING CRF RECEPTOR SIGNALING
#176TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN
#177Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau
#178METHODS OF DETECTING AND TREATING PULMONARY HYPERTENSION
#179METHODS, ASSAYS, AND SYSTEMS RELATING TO SAKT
#180Enzymatically responsive magnetic particles and their use
#181ASSAY TO MEASURE EFFICACY OF CDK8/19 INHIBITORS
#182Degradation resistant peptide based biosensors
#183Distinguishing antagonistic and agonistic anti B7-H1 antibodies
#184Method for high-throughput protein detection with two antibody microarrays
#185Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#186Methods for measurement of inhibition of c-Jun N-terminal kinase in skin
#187Method for detecting protein modifications using specific antibodies
#188Peptides derived from NCAPG2 and their use
#189Biomarker for parkinson's disease and use thereof
#190STAT3 phosphorylation during graft-versus-host disease
#191Methods apparatuses and systems for detecting and quantifying phosphoproteins
#192Detection of the degree of exposure to chemical warfare nerve agents and organophosphate pesticides with lateral flow assays
#193NEUROFIBROMIN/DOPAMINE SIGNALING AS A BIOMARKER FOR COGNITIVE AND BEHAVIORAL PROBLEMS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
#194MODIFIED PLANTS
#195Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#196Human blood molecular biodosimeter panel for distinguishing radiation exposure from inflammation stress
#197Peptides derived from NCAPG2 and their use
#198DETECTION AND TREATMENT OF CANCER
#199Method of diagnosis, prognostic or treatment of neurodegenerative disease
#200USE OF NEUREGULIN-4 FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND NECROTIZING ENTEROCOLITIS
#201ASSAY TO DETERMINE LRRK2 ACTIVITY IN PARKINSON'S DISEASE
#202ASSAYS FOR DETECTING MODIFIED COMPOUNDS
#203Excimer forming compounds
#204Proteasome inhibition assay and methods of use
#205Antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related kinase phosphorylated at position 1989 and their use
#206Kits to assay kinase activity
#207Difference gel electrophoresis of phosphoproteome
#208Methods of determining response to therapy
#209Phosphohistidine and phosphotyrosine analogues
#210Materials and Methods Relating to Pancreatic Cancer
#211Methods of treating fragile X syndrome and related disorders
#212SCREENING METHODS USING FYN IN COMBINATION WITH TAU PROTEIN
#213Preventive and therapeutic drug for cartilaginous hyperplasia and method of screening for the same
#214MPS peptides and use thereof
#215Methods for measurement of inhibition of c-Jun N-terminal kinase in skin
#216Methods for predicting and improving the survival of colorectal cancer patients
#217Activated HER3 as a marker for predicting therapeutic efficacy
#218Combination therapies for malaria
#219Diagnostic testing in dementia and methods related thereto
#220GI PROTEIN PHOSPHORYLATION AS MARKER FOR SCOLIOSIS AND SCOLIOSIS PROGRESSION, METHODS OF INCREASING GIPCR SIGNALING IN SCOLIOTIC SUBJECTS
#221METHODS FOR MONITORING TREATMENT RESPONSE AND RELAPSE IN BREAST CANCER
#222METHOD FOR MONITORING METASTASIS OF CANCER CELLS USING CELLS CULTURED IN THREE DIMENSIONAL COLLAGEN ENVIRONMENT
#223Method for determining prognosis of cancer
#224Method for reducing blood glucose
#225METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#226Methods of using U2-OS cells to identify potential sweet taste modulators
#227METHODS, COMPOSITIONS AND KITS FOR PROMOTING MOTOR NEURON SURVIVAL AND TREATING AND DIAGNOSING NEURODEGENERATIVE DISORDERS
#228Method for monitoring cancer and/or inflammatory reaction based on RelB phosphorylation
#229UREIDO-PYRAZOLE DERIVATIVES
#230Microvesicle histone H2AX as a biomarker for genotoxic stress
#231SYSTEMS AND METHODS FOR FACILITATING DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER BASED ON DETECTION OF HER3 ACTIVATION
#232Nanopipette device and method for subcellular analysis
#233FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOF
#234Reagent for diagnosing tumor, pharmaceutical composition, and screening method
#235PERFLUORO-TERT-BUTYL HYDROXYPROLINE
#236MDL-1 ligand
#237METHODS OF MODULATING DLK STABILITY
#238MARKER FOR DEPRESSION, ASSAY METHOD, METHOD FOR DETERMINING DEPRESSION, SCREENING METHOD FOR ANTIDEPRESSANTS, AND KIT
#239Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#240BIOMARKERS ASSOCIATED WITH CDK INHIBITORS
#241PROGRANULIN AS MARKER FOR AUTOIMMUNE DISORDERS
#242Diagnostic method based on large scale identification of post-translational modification of proteins
#243COMPOSITIONS AND METHODS FOR PROGNOSIS AND TREATMENT OF CANCER
#244COMPOSITIONS AND METHODS RELATED TO DORMANT SENESCENCE-PRONE CELLS (DSPC)
#245iASPP phosphorylation and metastatic potential
#246Method of inhibiting or treating cancer metastasis
#247Method for measuring ATR inhibition mediated increases in DNA damage
#248Methods and compositions for treating alzheimer's disease
#249Methods of measuring levels of phosphorylated neuronal nitric oxide synthase
#250METHODS AND COMPOSITIONS FOR DETECTING THE ACTIVATION STATE OF MULTIPLE PROTEINS IN SINGLE CELLS
#251ENDOTHELIAL NITRIC OXIDE SYNTHASE
#252Phosphorylated Akt-specific capture agents, compositions, and methods of using and making
#253Agents useful for treating obesity, diabetes and related disorders
#254METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE
#255Beclin 1 phosphorylation
#256Cell-Based Assays For Post-Translational Enzyme Activity
#257SH2 domain variants
#258COMPOSITIONS AND METHODS FOR PROGNOSIS AND TREATMENT OF CANCER
#259Methods and Compositions for Characterizing Phenotypes Using Kinome Analysis
#260Methods and products relating to GSK3β regulation
#261Protein expression analyses for identifying genotoxic compounds
#262Method for predicting the response to HER2-directed therapy
#263KITS FOR MULTIPARAMETRIC PHOSPHO ANALYSIS
#264Chronic Traumatic Encephalopathy in Blast-Exposed Individuals
#265Detection and treatment of cancer
#266PHOSPHOCOFILIN: COFILIN CO-LOCALIZATION INTENSITY AS A PREDICTOR OF METASTATIC RECURRENCE
#267Anti-GAP43 antibody
#268Personalized medicine for the prediction of therapy targeting the hedgehog pathway
#269Phosphorylation of histones and uses thereof
#270Assays for detecting modified compounds
#271Method and apparatus for measuring phosphorylation kinetics on large arrays
#272Target of the phosphoinositide 3-kinase pathway
#273Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis
#274MPHOSPH1 peptides and vaccines including the same
#275Methods and kits for diagnosing Sjögren's syndrome
#276Immunoaffinity isolation of modified peptides from complex mixtures
#277Use of phospho-Akt as a biomarker of drug response
#278Methods for identifying modulators of murine double minute 2
#279Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
#280Tyrosine-phosphorylated WBP2, a novel cancer target and biomarker
#281Method for cancer detection
#282BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF
#283Reagents and methods for phosphorylation/dephosphorylation analyses
#284Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
#285SCREENING METHOD
#286Tyrosine, serine and threonine phosphorylation sites
#287Methods and compositions for detecting the activation state of multiple proteins in single cells
#288Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#289Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#290KITS FOR MULTIPARAMETRIC PHOSPHO ANALYSIS
#291METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS
#292Immunoaffinity isolation of modified peptides from complex mixtures
#293CALIBRATION REAGENT AND USES THEREOF
#294Kit for detecting and measuring element tagged kinases and phosphatases by inductively coupled plasma mass spectrometry
#295AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy
#296Tumor biomarker
#297Assays for detecting modified compounds
#298Mass spectrometry assay for and regulon activity
#299COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1
#300Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1